Lieberman Gerald M's Form 4 filing
Entera Bio Ltd. (ENTX) · filed Nov 15, 2022
- Accession no.
- 0001178913-22-004052
- Filed
- Nov 15, 2022
- Trade date
- Nov 14, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market purchases total $28.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lieberman Gerald MCIK 0001234346 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | Ordinary Shares, par value NIS 0.0000769 per share | PPurchaseAcquired | +34,000 | $0.57 | +$19,380 | 194,209 | Direct | |
| Nov 14, 2022 | Ordinary Shares, par value NIS 0.0000769 per share | PPurchaseAcquired | +4,000 | $0.56 | +$2,240 | 6,200 | Indirect | |
| Nov 14, 2022 | Ordinary Shares, par value NIS 0.0000769 per share | PPurchaseAcquired | +4,000 | $0.56 | +$2,240 | 6,200 | Indirect | |
| Nov 14, 2022 | Ordinary Shares, par value NIS 0.0000769 per share | PPurchaseAcquired | +4,000 | $0.56 | +$2,240 | 6,200 | Indirect | |
| Nov 14, 2022 | Ordinary Shares, par value NIS 0.0000769 per share | PPurchaseAcquired | +4,000 | $0.59 | +$2,360 | 6,200 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.